- Home
- NRP vs NKTR Comparison
NRP vs NKTR Comparison
Compare NRP & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRP
- NKTR
- Stock Information
- Founded
- NRP 2002
- NKTR 1990
- Country
- NRP United States
- NKTR United States
- Employees
- NRP N/A
- NKTR N/A
- Industry
- NRP Coal Mining
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- NRP Energy
- NKTR Health Care
- Exchange
- NRP Nasdaq
- NKTR Nasdaq
- Market Cap
- NRP 1.4B
- NKTR 1.2B
- IPO Year
- NRP N/A
- NKTR 1994
- Fundamental
- Price
- NRP $104.99
- NKTR $62.67
- Analyst Decision
- NRP
- NKTR Strong Buy
- Analyst Count
- NRP 0
- NKTR 6
- Target Price
- NRP N/A
- NKTR $91.67
- AVG Volume (30 Days)
- NRP 22.6K
- NKTR 937.6K
- Earning Date
- NRP 11-04-2025
- NKTR 11-06-2025
- Dividend Yield
- NRP 2.89%
- NKTR N/A
- EPS Growth
- NRP N/A
- NKTR N/A
- EPS
- NRP 10.64
- NKTR N/A
- Revenue
- NRP $219,503,000.00
- NKTR $74,934,000.00
- Revenue This Year
- NRP N/A
- NKTR N/A
- Revenue Next Year
- NRP N/A
- NKTR N/A
- P/E Ratio
- NRP $9.76
- NKTR N/A
- Revenue Growth
- NRP N/A
- NKTR N/A
- 52 Week Low
- NRP $86.83
- NKTR $6.48
- 52 Week High
- NRP $113.04
- NKTR $63.92
- Technical
- Relative Strength Index (RSI)
- NRP 50.34
- NKTR 66.42
- Support Level
- NRP $102.59
- NKTR $53.73
- Resistance Level
- NRP $108.71
- NKTR $63.92
- Average True Range (ATR)
- NRP 2.73
- NKTR 4.20
- MACD
- NRP -0.38
- NKTR -0.78
- Stochastic Oscillator
- NRP 32.64
- NKTR 88.60
About NRP Natural Resource Partners LP Limited Partnership
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.